AbbVie nears $11B deal for Apogee Therapeutics

Name: AbbVie nears $11B deal for Apogee Therapeutics
Uploaded: 2026-06-19T20:09:26Z
Duration: 34 s
Description: Fox Business reports on AbbVie's potential acquisition of Apogee Therapeutics for $10.9 billion in cash. The deal, which values Apogee at a 60% premium, is expected to be announced as early as Monday, marking a significant development in the biotech sector.

The Claman Countdown · FBN · Jun 19, 2026 · 34s

Sign Up Now

Already a subscriber?

Fox Business reports on AbbVie's potential acquisition of Apogee Therapeutics for $10.9 billion in cash. The deal, which values Apogee at a 60% premium, is expected to be announced as early as Monday, marking a significant development in the biotech sector.

Watch AbbVie nears $11B deal for Apogee Therapeutics - The Claman Countdown | FOX One